RxDoctor Payments Data

Allison Willkom, DPM

Podiatrist · Coon Rapids, MNNPI 1699137372

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 58.0% of the total. Reporting peaked in 2022 at $2,058 and has fallen 86.2% since, to $284 in 2025.

$5,353in general payments, 2019–2025

Across 69 payments — averaging $77.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Foundation Medical, LLC$737
  • Gemini Medical LLC$462
  • Arthrex$278
  • Orthofix Medical, Inc.$173
  • Bone Support Inc.$133
  • plus $467 from 8 others

What the payments were for

  • Travel & lodging$2,10839%
  • Food & beverage$2,78352%
  • Education$4629%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)33$3,103
Foundation Medical, LLC6$737
Gemini Medical LLC1$462
Arthrex4$278
Orthofix Medical, Inc.8$173
Bone Support Inc.1$133
Organogenesis Inc.5$124
Johnson & Johnson1$97
Lifenet Health3$76
Integra Lifesciences Corporation3$65
Dynasplint Systems Inc.1$44
Kerecis Limited1$28
Convatec Inc.1$18
Treace Medical Concepts, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,353 in reported general payments places this provider in the 85th percentile of 105 podiatrist providers in Minnesota.

See all podiatrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$34,782
Medicare patients
104
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole15$272

Paid to pharmacies, not to this prescriber.

Other podiatrist in Coon Rapids

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →